©The Author(s) 2025.
World J Hepatol. Nov 27, 2025; 17(11): 110698
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110698
Published online Nov 27, 2025. doi: 10.4254/wjh.v17.i11.110698
Table 6 Correlation of cytokeratin 18 fragment with clinical factors: Non-invasive tests
| Factors | CMRF | Modified CMRF | Fibrosis-4 index | Steatosis-associated fibrosis estimator score | Liver stiffness | Controlled attenuation parameter | FibroScan-aspartate aminotransferase | |
| Cytokeratin 18 fragment | R | 0.1676 | 0.2330 | 0.1090 | 0.2415 | 0.1432 | 0.1963 | 0.4560 |
| n | 123 | 123 | 123 | 123 | 113 | 113 | 113 | |
| P value | 0.06179 | 0.00891 | 0.22628 | 0.00667 | 0.12676 | 0.03547 | < 0.00001 |
- Citation: Ichikawa T, Miuma S, Yamashima M, Yamamichi S, Koike M, Nakano Y, Yajima H, Miyazaki O, Ikeda T, Okamura T, Komatsu N, Yoshino M, Miyaaki H. Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease. World J Hepatol 2025; 17(11): 110698
- URL: https://www.wjgnet.com/1948-5182/full/v17/i11/110698.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i11.110698